The Impact of Physical Exercise on Obesity in a Cohort of Southern Italian Obese Children: Improvement in Cardiovascular Risk and Immune System Biomarkers.
cardiovascular risk
childhood obesity
defensins
inflammation
interleukins
physical exercise
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
29 12 2022
29 12 2022
Historique:
received:
19
11
2022
revised:
24
12
2022
accepted:
26
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
11
1
2023
Statut:
epublish
Résumé
Background: Childhood obesity (CO) is a serious medical condition affecting approximately 120 million children and adolescents worldwide. It is characterized by a persistent inflammatory state with inflammatory markers overexpressed, which in turn leads to a higher cardiovascular risk. It is well known that physical exercise reduces the inflammatory state in obese children. In the present study, we evaluated various biochemical parameters in obese children performing physical exercise compared to a group of obese sedentary children. Hence, the objective is to identify a panel of biomarkers to prevent numerous obesity-related complications. Methods: We examined two populations: 44 sedentary obese children (OSe), recruited on 5 November 2018 from Santobono−Pausilipon Children’s Hospital, Naples (Italy) of age = 11 ± 3.3 and 30 obese children who practice sport (OSp) of age = 10 ± 2.5. We observed a significant variation in some biochemical parameters such as white blood cells, C-reactive protein (CRP), glycemia and insulinemia. Moreover, we determined the levels of interleukins, chemokines and defensins by ELISA assay. Results: Our results showed a reduction in serum level of glycemia (p-value < 0.001), neutrophils (p-value < 0.05) and CRP (p-value < 0.05), whereas no relevant variations have been reported in insulin levels. Moreover, we found a decrease in serum levels of PDGF-β (p-value < 0.05), IL-9 (p-value < 0.01), IL-6 (p-value < 0.0001), IL-8 (p-value < 0.0001), IP-10 (p-value < 0.01), Eotaxin (p-value < 0.0001) and GM-CSF (p-value < 0.01) in OSp population in comparison to OSe. At the same time, we did not observe any significant variation in serum levels of IL-1ra and IL-17 between the two populations. On the other hand, we found an increase in HNP-1 (p-value < 0.0001) and HBD1 (p-value < 0.01) in OSp if compared to OSe. Conclusions: This study shed light on the role of physical exercise on CO, demonstrating in our population that an early evaluation of some biochemical parameters could be an assumption to prescribe physical exercise in order to monitor and prevent childhood obesity and related disorders.
Identifiants
pubmed: 36612926
pii: ijerph20010602
doi: 10.3390/ijerph20010602
pmc: PMC9819595
pii:
doi:
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Antibiotics (Basel). 2020 Apr 21;9(4):
pubmed: 32326312
Annu Rev Clin Psychol. 2020 May 7;16:351-378
pubmed: 32097572
PLoS One. 2012;7(2):e31319
pubmed: 22363616
Cell Metab. 2019 May 7;29(5):1028-1044
pubmed: 30982733
PLoS One. 2011 Feb 18;6(2):e17264
pubmed: 21365005
Clin Chem Lab Med. 2019 Dec 10;58(9):1385-1406
pubmed: 31821163
J Inflamm Res. 2021 Feb 25;14:567-573
pubmed: 33658829
Med Sci Sports Exerc. 2010 Nov;42(11):1981-6
pubmed: 20386340
J Am Soc Nephrol. 2004 Nov;15(11):2792-800
pubmed: 15504932
Proc Nutr Soc. 2001 Aug;60(3):349-56
pubmed: 11681809
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
JPEN J Parenter Enteral Nutr. 2008 Nov-Dec;32(6):633-7
pubmed: 18974243
Mediators Inflamm. 2005 Aug 14;2005(3):180-3
pubmed: 16106106
Prim Care. 2021 Sep;48(3):505-515
pubmed: 34311854
Psychiatr Clin North Am. 2011 Dec;34(4):829-40
pubmed: 22098807
Horm Res Paediatr. 2012;78(1):31-9
pubmed: 22832157
Nutrients. 2022 Aug 19;14(16):
pubmed: 36014927
Pediatr Exerc Sci. 2015 Nov;27(4):454-62
pubmed: 25902558
Physiol Rev. 2013 Jul;93(3):993-1017
pubmed: 23899560
Curr Opin Pediatr. 2020 Dec;32(6):805-815
pubmed: 33105275
Int J Environ Res Public Health. 2020 Dec 16;17(24):
pubmed: 33339141
Eur J Pharmacol. 2008 Jan 28;579(1-3):1-12
pubmed: 18021769
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1038-46
pubmed: 18765677
PLoS One. 2019 Sep 19;14(9):e0222295
pubmed: 31537016
Int J Environ Res Public Health. 2021 Dec 16;18(24):
pubmed: 34948868
Eur Heart J. 2004 Feb;25(4):349-55
pubmed: 14984925
Allergy. 2021 Nov;76(11):3549-3552
pubmed: 34086364
J Clin Res Pediatr Endocrinol. 2014 Sep;6(3):129-43
pubmed: 25241606
Cytokine. 2016 Jan;77:1-9
pubmed: 26476404
Curr Sports Med Rep. 2019 Aug;18(8):287-291
pubmed: 31389870
J Clin Endocrinol Metab. 2014 Mar;99(3):E474-8
pubmed: 24423308
Nutrients. 2022 Feb 02;14(3):
pubmed: 35277002
BMC Public Health. 2018 Nov 6;18(1):1232
pubmed: 30400967
Front Pediatr. 2021 Jan 12;8:581461
pubmed: 33511092
Sleep Med Clin. 2022 Mar;17(1):111-116
pubmed: 35216758
Biomolecules. 2019 Jun 18;9(6):
pubmed: 31216758
Diabetes Metab Syndr Obes. 2016 Mar 15;9:83-9
pubmed: 27042133
Bosn J Basic Med Sci. 2020 May 01;20(2):149-156
pubmed: 31509733
N Engl J Med. 2011 Nov 17;365(20):1876-85
pubmed: 22087679
Redox Rep. 2016 Nov;21(6):271-80
pubmed: 26865084
Microvasc Res. 2022 Jan;139:104254
pubmed: 34534571
Front Endocrinol (Lausanne). 2019 Jun 04;10:342
pubmed: 31214120
Diabetes Care. 2008 Mar;31(3):576-82
pubmed: 18083792
J Appl Physiol (1985). 2005 Apr;98(4):1154-62
pubmed: 15772055
Nutrients. 2021 Apr 25;13(5):
pubmed: 33922998
Cytokine. 2020 Feb;126:154925
pubmed: 31759309
Mediators Inflamm. 2008;2008:109502
pubmed: 19148295
Biofactors. 2021 Jul;47(4):674-685
pubmed: 33979459
Mayo Clin Proc. 2017 Feb;92(2):251-265
pubmed: 28065514
Microorganisms. 2021 Jun 30;9(7):
pubmed: 34209064
Diabetes. 2017 Apr;66(4):1008-1021
pubmed: 28122789
Int J Environ Res Public Health. 2022 Jun 05;19(11):
pubmed: 35682490
J Interferon Cytokine Res. 2019 Jan;39(1):6-21
pubmed: 29889594